IP Library Granted Patent US 8,124,341
Granted Patent B2
US 8,124,341 · App. 12/699,711 · Granted Feb 28, 2012

Genes and polypeptides relating to hepatocellular or colorectal carcinoma

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,124,341
App. No.
12/699,711
Granted
Feb 28, 2012
Kind
B2
Abstract

The present application provides novel human genes WDRPUH and KRZFPUH, and PPIL1 whose expression is markedly elevated in a great majority of HCCs and colorectal cancers, respectively, compared to corresponding non-cancerous tissues, as well as novel human gene APCDD1 whose expression is elevated in primary colon cancers and down-regulated in response to the transduction of wild-type APC1 into colon-cancer cells. The genes and polypeptides encoded by the genes can be used, for example, in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease.

Claims (3)

1. A method for diagnosing a hepatocellular carcinoma, said method comprising the steps of:

(a) detecting the expression level of the gene encoding the amino acid sequence of SEQ ID NO: 2 in a biological sample comprising liver tissue(s) or liver cell(s), wherein the expression level is detected by detecting the mRNA encoding the amino acid sequence of SEQ ID NO: 2 or the protein comprising the amino acid sequence of SEQ ID NO: 2; and

(b) comparing the expression level detected in step (a) with that in a normal sample, where a higher than normal expression level is indicative of hepatocellular carcinoma.